Oracle Investment Management Inc Mirati Therapeutics, Inc. Call Options Transaction History

Oracle Investment Management Inc

  • $43.2 Million
  • Q3 2024

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2022

Feb 14, 2023
SELL
$41.27 - $98.62 $1.03 Million - $2.47 Million
-25,000 Reduced 25.0%
75,000 $3.4 Million
Q3 2022

Nov 14, 2022
BUY
$59.5 - $86.7 $2.34 Million - $3.42 Million
39,400 Added 65.02%
100,000 $1.1 Million
Q2 2022

Aug 15, 2022
BUY
$39.16 - $88.71 $2.37 Million - $5.38 Million
60,600 New
60,600 $753,000

Others Institutions Holding MRTX

# of Institutions
16
Shares Held
3.57M
Call Options Held
0
Put Options Held
36.6K
View Full List

About Mirati Therapeutics, Inc.

MRTX Quotes by TradingView
  • Ticker MRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,609,800
  • Description
  • Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...
More about MRTX
Track This Portfolio

Track Oracle Investment Management Inc Portfolio

Follow Oracle Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oracle Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Oracle Investment Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email